1![Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris](https://www.pdfsearch.io/img/98cd59a4b700b5fd21182275063c97dc.jpg) | Add to Reading ListSource URL: www.hemapherese.frLanguage: English - Date: 2016-05-16 12:22:49
|
---|
2![HUS ParisMode de compatibilité] HUS ParisMode de compatibilité]](https://www.pdfsearch.io/img/66c28e5aa684cc06fa7f9acce09eb857.jpg) | Add to Reading ListSource URL: www.hemapherese.frLanguage: English - Date: 2016-05-16 12:27:10
|
---|
3![Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report](https://www.pdfsearch.io/img/49a26304fb58736a37b1e77bd79e2491.jpg) | Add to Reading ListSource URL: www.jmedicalcasereports.comLanguage: English |
---|
4![Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit](https://www.pdfsearch.io/img/376a07bf33362ac108207e43ad5d2b2c.jpg) | Add to Reading ListSource URL: pbs.gov.auLanguage: English - Date: 2014-10-01 21:51:53
|
---|
5![Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology](/pdf-icon.png) | Add to Reading ListSource URL: pbs.gov.auLanguage: English - Date: 2015-03-12 23:53:04
|
---|
6![Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit](https://www.pdfsearch.io/img/625bd04f0232628332b1cb46248d9ec7.jpg) | Add to Reading ListSource URL: pbs.gov.auLanguage: English - Date: 2015-03-12 23:53:04
|
---|
7![Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit](https://www.pdfsearch.io/img/4d8b312b519f3fd3e7f0e1adc7cc4f04.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-13 00:39:15
|
---|
8![Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-13 00:39:15
|
---|
9![Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab - Continuing PBS authority application Atypical Haemolytic Uraemic Syndrome (aHUS) - eculizumab - Continuing PBS authority application](https://www.pdfsearch.io/img/d9ec2a02b379b18cc0ce56a2341787aa.jpg) | Add to Reading ListSource URL: www.humanservices.gov.auLanguage: English - Date: 2015-03-05 22:46:33
|
---|
10![Atypical Haemolytic Uraemic Syndrome (aHUS) – eculizumab
Initial PBS authority application Atypical Haemolytic Uraemic Syndrome (aHUS) – eculizumab
Initial PBS authority application](https://www.pdfsearch.io/img/c23c99a7ce1dfe72a87372744d1d9889.jpg) | Add to Reading ListSource URL: www.humanservices.gov.auLanguage: English - Date: 2015-03-09 19:12:48
|
---|